20 companies backed by ARCH Venture Partners, including Seaport Therapeutics, Be Biopharma, Mirador Therapeutics.
ARCH Venture Partners accounts for 90 tracked companies with verified cap-table data, 90 of which disclose round sizes totalling $22B. The median disclosed raise is $150M, and the largest is Resilience at $3.4B, ahead of Altos Labs ($3B) and Beam Therapeutics ($1B).
The names that recur most often on these portfolio cap tables are ARCH Venture Partners (90 companies), Alexandria Venture Investments (15 companies), GV (11 companies), F-Prime Capital (10 companies), Polaris Partners (9 companies), Altitude Life Science Ventures (6 companies). By latest disclosed round, the market skews Series A (38), Series B (24), Series C (14), Series D (4).
Companies tracked: 90
Disclosed funding total: $22B across 90 companies
Median disclosed raise: $150M
Largest raise: Resilience — $3.4B
Stage mix: Series A 38 · Series B 24 · Series C 14 · Series D 4
